登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>Endotoxin >RES-A056

Recombinant Factor C Endotoxin Detection Kit

For research use only.
   

  1. Comparable to LAL method - Endpoint fluorescent assay, comparable to other chromogenic quantitative LAL methods.
  2. High specificity - Unlike LAL Assay, as Factor G is absent from the rFC test kit, false-positive results due to β-glucan activation are not expected to occur.
  3. Accuracy - Traceability of endotoxin standards in the kit against USP Standard (Catalog No: 1235503).
  4. Fast time to results - 1 hours.
  5. High sensitivity - Sensitivity range from 0.005-5 EU/mL.
  6. Extensive validation – Verification on multiplex biological products, kinds of microplate readers and various buffer systems, comprehensive validation of specificity, sensitivity, precision, accuracy, applicability, and other aspects according to the parameters listed in the EUROPEAN PHARMACOPOEIA 11.0 and USP chapter<<1225>>.
  7. Sustainable resource - Get rid of dependence on animal derived reagents, reduce dependence on horseshoe crab resources and fishing pressure and realize long-term supply.
  8. Good inter batch consistency - Batch consistency of products is guaranteed due to the use of genetic recombination technology for production.

重组C蛋白:拯救鲎宝贝,共创绿色未来

Endotoxin PRODUCT Impression

原理(Assay Principles)

The Recombinant Factor C Endotoxin Detection Kit is a novel endotoxin detection method based on the recombination technology. Recombinant Factor C, as the first component of the horseshoe crab coagulation cascade reaction, is activated by an endotoxin. The activated Factor C can cleave the fluorogenic substrate and produce a fluorescent signal. The increase of fluorescence signal is positively correlated with the dosage of endotoxin. The experiment is carried on a white 96-well plate and is measured at time zero and after a one-hour 37℃ incubation. Use a fluorescence microplate reader to measure at the wavelength of ex/em = 380/440 nm to determine whether the sample is contaminated by endotoxin.

Assay Principles

产品描述(Product Details)

Assay Type FRET
Analyte Endotoxin
Format 96T
Regulatory Status RUO
Sensitivity 0.005 EU/mL
Standard Curve Range 0.005 EU/mL-5 EU/mL
Assay Time 1 hr
Suitable Sample Type For the quantitative determination of endotoxin from pharmaceutical products, biologicals for injection and some media for tissue cultures.
Sample volume 100 μL

组分(Materials Provided)

ID Components Size
RES056-C01 Bacterial Endotoxin Standard 1 vial
RES056-C02 Recombinant Factor C Protein 96 tests
RES056-C03 Fluorogenic Substrate 96 tests
RES056-C04 Water for Bacterial Endotoxins Test 50 mL

应用说明(Application)

Production process (Process control)

  1. Raw materials
  2. Water testing
  3. Intermediate product testing

Final product (Release testing)

  1. Parenteral drugs & Biological products
  2. Infusion, injection or tranfusion cells
  3. Cell culture media
  4. Medical devices


It is for research use only.

存储(Storage)

Unopened kit should be stored at 2°C-8°C upon receiving.

Find the expiration date on the outside packaging and do not use reagents past their expiration date.

 

活性(Bioactivity)-Fluorescence Please refer to DS document for the assay protocol.

Endotoxin FLUORESCENCE

Take the logarithm of the concentration of the Endotoxin working standard solution as the abscissa, take the ΔRFU as the ordinate. Fitting the standard curve with linearly model, and the correlation coefficient R should be ≥ 0.98 (QC tested).

Endotoxin FLUORESCENCE

The rFC method was employed to detect endotoxin residues in β-glucan at concentrations of 10ug/mL and 1ug/mL. No non-specific signals were detected. In contrast, the dynamic chromogenic method used for β-glucan detection resulted in the detection of endotoxin and non-specific signals. This indicates that recombinant factor C does not react with β-glucan, demonstrating the good specificity of the rFC method.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定